PMID- 15640547 OWN - NLM STAT- MEDLINE DCOM- 20050602 LR - 20191109 IS - 1046-3976 (Print) IS - 1046-3976 (Linking) VI - 15 IP - 3 DP - 2004 Fall TI - Endocrine tumor syndromes in infancy and childhood. PG - 223-6 AB - Of endocrine disorders that present in the pediatric age range, three heritable tumor syndromes have received a large amount of attention over the past decade, because the relevant genes have been discovered and we have begun to understand the role of some of the proteins involved. In this short review article, the dominantly inherited tumor syndromes multiple endocrine neoplasia type 1 (MEN1), caused by mutations in the menin gene, type 2 (MEN2), caused by mutations in the RET protooncogene, and von Hippel-Lindau disease (VHL), caused by VHL gene abnormalities including mutations, are discussed with an emphasis on the age and mode of presentation of the constituent tumors. Also, current screening and/or treatment guidelines are included. FAU - de Krijger, Ronald R AU - de Krijger RR AD - Department of Pathology, Josephine Nefkens Institute, Erasmus MC-University Medical Center, Rotterdam, The Netherlands. r.dekrijger@erasmusmc.nl LA - eng PT - Journal Article PT - Review PL - United States TA - Endocr Pathol JT - Endocrine pathology JID - 9009288 RN - 0 (MEN1 protein, human) RN - 0 (Proto-Oncogene Proteins) RN - 0 (Tumor Suppressor Proteins) RN - EC 2.3.2.27 (Ubiquitin-Protein Ligases) RN - EC 2.3.2.27 (Von Hippel-Lindau Tumor Suppressor Protein) RN - EC 2.7.10.1 (Proto-Oncogene Proteins c-ret) RN - EC 2.7.10.1 (Receptor Protein-Tyrosine Kinases) RN - EC 6.3.2.- (VHL protein, human) SB - IM MH - Child MH - Child, Preschool MH - Humans MH - Infant MH - Infant, Newborn MH - Multiple Endocrine Neoplasia Type 1/genetics/*pathology MH - Multiple Endocrine Neoplasia Type 2a/genetics/*pathology MH - Mutation MH - Proto-Oncogene Proteins/genetics MH - Proto-Oncogene Proteins c-ret MH - Receptor Protein-Tyrosine Kinases/genetics MH - Tumor Suppressor Proteins/genetics MH - Ubiquitin-Protein Ligases/genetics MH - Von Hippel-Lindau Tumor Suppressor Protein MH - von Hippel-Lindau Disease/genetics/*pathology RF - 17 EDAT- 2005/01/11 09:00 MHDA- 2005/06/03 09:00 CRDT- 2005/01/11 09:00 PHST- 2005/01/11 09:00 [pubmed] PHST- 2005/06/03 09:00 [medline] PHST- 2005/01/11 09:00 [entrez] AID - EP:15:3:223 [pii] AID - 10.1385/ep:15:3:223 [doi] PST - ppublish SO - Endocr Pathol. 2004 Fall;15(3):223-6. doi: 10.1385/ep:15:3:223.